Baxter Healthcare Corporation

About Baxter Healthcare Corporation

Backed by over 85 years of experience in parenterals, Baxter’s BioPharma Solutions (BPS) business collaborates with pharmaceutical companies to support commercialization objectives for their molecules. BPS is a premier CMO with a focus on specialized sterile injectable manufacturing designed to meet complex and traditional sterile challenges. 

Our state-of-the-art, award-winning facilities have primary locations in: 
-Bloomington, Indiana, USA facility is a leader in sterile contract manufacturing and offers form/fill/finish services and solutions for injectables designed to meet traditional sterile manufacturing challenges.
-Halle/Westfalen, Germany facility has over 60 years of experience and is recognized as a world-class manufacturer of oncology products and other sophisticated compounds.

BPS can support your pharmaceutical needs with a broad portfolio of sterile fill/finish production capabilities, and our reputation is built on the high-quality products we manufacture for our clients in a cGMP environment. Our delivery systems include: prefilled syringes, liquid/lyophilized vials, diluents for reconstitution, powder-filled vials, and sterile crystallization. Our drug categories include: small molecules, biologics, vaccines, cytotoxics, highly potent compounds, and ADCs (antibody-drug conjugates). From formulation and development, through commercial launch, our extensive, customized support services can guide you through marketplace complexities, helping you achieve the full potential for your drug molecule. Whether you face formulation challenges, clinical supply hurdles, surges in demand due to market fluctuations, risk mitigation concerns, or patent expiry challenges, we offer tailored and versatile solutions to help achieve your commercialization objectives. 


Certifications
  • US
  • 2015
    On CPHI since
  • 2
    Certificates
  • 5000+
    Employees
Company types
Contract Service
Contact info
Meet us at

CPHI Frankfurt 2022

Messe Frankfurt, Frankfurt, Germany
1-3 November 2022

Products from Baxter Healthcare Corporation (10)

  • Prefilled Syringes

    Product Prefilled Syringes

    Baxter (BioPharma Solutions) offers a wide range of traditional sterile manufacturing products which includes prefilled syringes. It offers expanded small-scale through high-volume sterile manufacturing. It can increase production potential and help ensure on-time delivery to meet product demand. By providing...
  • Lyophilized Vials

    Product Lyophilized Vials

    Baxter (BioPharma Solutions) offers a wide range of complex sterile manufacturing/traditional sterile manufacturing products which includes lyophilized vials. The process of freeze drying can achieve product stability, and improved shelf-life. It offers individual filling suites with lyophilization capacity, ...
  • Liquid Vials

    Product Liquid Vials

    Baxter (BioPharma Solutions) offers a wide range of traditional sterile manufacturing products which includes liquid vials. It can helps clients to meet developmental, clinical, and commercial liquid vial manufacturing needs. High-volume filling and multiple, dedicated vial-filling suites allow to expand prod...
  • Powder Filled Vials

    Product Powder Filled Vials

    Baxter (BioPharma Solutions) offers a wide range of complex sterile manufacturing products which includes powder filled vials. It is a type of cytotoxics. It offers filling of powder filled vials at our highly experienced Halle/Westfalen, Germany facility. In addition to continuous monitoring of temperature, ...
  • Diluents for Reconstitution

    Product Diluents for Reconstitution

    Baxter (BioPharma Solutions) offers a wide range of traditional sterile manufacturing products which includes diluents for reconstitution. It offer both customer and patient benefits. When compared to vials, they can enhance and improve patient safety such as less steps for reconstitution; reduced contaminati...
  • Cytotoxics

    Product Cytotoxics

    Baxter (BioPharma Solutions) offers a wide range of complex sterile manufacturing products which includes cytotoxics. It is the most highly sophisticated and sensitive drugs to handle and produce. The barrier technology ensures your cytotoxic product is manufactured under precisely controlled temperature, rel...
  • Highly Potent Compounds

    Product Highly Potent Compounds

    Baxter (BioPharma Solutions) offers a wide range of complex sterile manufacturing products which includes highly potent compounds. It presents many challenges due to the complex handling required for toxic substances. Utilizing cRABs (closed restricted access barrier system) for commercial manufacturing allow...
  • Biologics

    Product Biologics

    Baxter (BioPharma Solutions) offers a wide range of complex sterile manufacturing products which includes biologics. It offers innovative filling line technologies that are specifically designed to protect your biologic's integrity and optimize yield of costly API. This manufacturing process optimization help...
  • Sterile Crystallization

    Product Sterile Crystallization

    Baxter (BioPharma Solutions) offers a wide range of complex sterile manufacturing products which includes sterile crystallization. It is a type of cytotoxics. It offers sterile crystallization of cytotoxic active pharmaceutical ingredients in a closed system. Sizes and options: poly ethylene bags (1 - 5 kg); ...
  • Antibody-Drug Conjugates

    Product Antibody-Drug Conjugates

    Baxter (BioPharma Solutions) offers a wide range of complex sterile manufacturing products which includes antibody-drug conjugates. It is a type of cytotoxics. It offers a combined approach for ADC to simplify the supply chain and provide comprehensive, coordinated and collaborative services for the developme...

Baxter Healthcare Corporation Resources (10)

  • Sponsored Content CPHI Podcast Series: Key Considerations in Selecting the Right CMO Partner

    In this month's episode we hear from Jayna Blake, Senior Project Manager for Technical Programs at Baxter BioPharma Solutions, on key considerations for successful CMO selection.
  • Brochure A Global Leader in Sterile Contract Manufacturing

    Our processes and systems are tailored to meet your parenteral manufacturing needs. We offer conventional sterile dosage forms, including prefilled syringes, liquid vials, lyophilized vials and cartridges as well as cost-saving diluents for reconstitution.
  • News Baxter announces $100M investment in biopharma solutions at German sterile fill/finish manufacturing facility

    Investment will add a syringe filling line, additional liquid and lyophilized (freeze dried) vial capacity and expand manufacturing footprint
  • Brochure Complex Sterile Manufacturing: More Than 60 Years of Oncology Experience

    Parenteral manufacturing can be a complicated process. Cytotoxics, antibody-drug conjugates (ADCs), highly potent compounds, biologics and lyophilized products present many challenges and require specialized understanding and expertise.
  • Sponsored Content Audits in the time of COVID-19 – Implications for a CMO

    Travel restrictions imposed by the pandemic have limited the ability of pharmaceutical companies and health authority personnel to travel and conduct in-person inspections of contract manufacturing organizations (CMOs). 

    Due to these limitations, both health authorities and CMOs must adapt and move to new processes for conducting audits. This can be done by leveraging innovation and technology solutions.

  • Brochure Maximize Your Molecule's Full Potential

    We know the high-stakes challenges you face in today's complex parenteral marketplace - and how the work we do is vital to the patients you serve. That's why we work closely with you at every step to help you achieve your molecule's full potential and your commercialization objectives.
  • News CPHI releases Pharma Trends 2022 report

    CPHI has launched its forward-looking pharma trend report for 2022 and it is now available to read on CPHI Online.
  • Whitepaper Seasonal Vaccine Manufacturing

    The production of seasonal vaccines, such as those for influenza, presents unique challenges to manufacturers due to the necessary time constraints resulting from annual strain selection. The limited-time span from strain selection to distribution requires most vaccine producers to rely on outsourcing partners to ensure timely production and supply. While the right facility and technical expertise are important, vaccine developers should also focus on securing a culture of speed and execution, shared expectations, and continuous improvement. This whitepaper from Baxter’s contract manufacturing business, BioPharma Solutions examines three key areas to evaluate when selecting an outsourcing partner for vaccines production to ensure quality and on-time delivery.
  • Podcast CPHI Podcast Series: Key Considerations in Selecting the Right CMO Partner

    In this episode we hear from Jayna Blake, Senior Project Manager for Technical Programs at Baxter BioPharma Solutions, on key considerations for successful CMO selection.
  • Webinar Rapid Tech Transfer of Vaccine Products

    The compressed timelines for technical transfer of COVID-19 projects were unprecedented and offered opportunities to identify and reflect on the unique capabilities required to meet these timelines, as well as the best practices applied to result in the fastest path to GMP production and supply reliability. This webinar is an opportunity for pharmaceutical companies to better understand how the selection of the right CMO is key not only save cost, but also time. Join us to learn more about why the following criteria are so important when selecting a CMO: Responsive and Expansive Supplier Networks Global Manufacturing and Regulatory Experience Collaborative Decision Making Experience and Agility Scientific Expertise